miRecule published in Clinical Cancer Research Dec 16, 2020 | ArchivedIntegrated genomic and functional microRNA analysis identifies miR-30-5p as a tumor suppressor and potential therapeutic nanomedicine in head and neck cancer – Clinical Cancer Research
miRecule featured by the BioHealth Capital Region Investment Conference Dec 16, 2020 | ArchivedmiRecule closes Seed Round at the second annual BioHealth Capital Region Investment Conference – BioBuzz
miRecule featured by the FSHD Society Dec 16, 2020 | ArchivedmiRecule, Inc., is developing a novel treatment for FSHD – FSHD Society
miRecule awarded grant by Friends of FSH Research Dec 16, 2020 | ArchivedAntisense Oligonucleotide-Antibody Conjugates to Treat FSHD – Friends of FSH Research
miRecule adds Maryland Momentum Fund to its Seed Round Dec 16, 2020 | ArchivedUSM Maryland Momentum Fund Invests $250,000 in $3.5M Seed Round of miRecule Inc. – USM Momentum Fund
